Safety of CIGB-814 in healthy Chinese volunteers
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This is a first-in-human study in China testing a new drug called CIGB-814 in healthy volunteers. The goal is to check how safe the drug is, how well it is tolerated, and how the body processes it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old.
- You are in good health with no major medical conditions.
- Your weight is at least 50 kg (men) or 45 kg (women) and your BMI is between 19 and 26.
- You have not taken any medications or supplements in the last 2 weeks.
- You do not smoke heavily, drink too much alcohol, or consume large amounts of caffeine.
- You are willing to use reliable birth control and not donate sperm or eggs during the study and for 6 months after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new antibody drug called CM583 in healthy people to see if it is safe and how the body handles it. It may help treat conditions related to certain proteins involved in pain and inflammation.
This trial tests a new drug, CGB3002, to see how safe it is and how the body processes it. Healthy volunteers are needed to help determine the right dose and check for side effects.
This trial tests a new experimental antibody called GNC-038 for people with moderate to severe rheumatoid arthritis (RA) that hasn't responded well enough to standard treatments. It aims to see if targeting specific immune cells can reduce inflammation and improve symptoms.
This study tests a new investigational drug called ISH0613 in healthy volunteers to see if it is safe and how the body processes it. It is the first time this drug is given to humans.
This study tests a new drug called GenSci120, given as multiple injections under the skin, to see if it is safe in healthy adults. It will also measure how the drug moves through the body and how it affects certain immune markers.
This study tests an experimental drug called BMS-986368 in healthy Chinese volunteers to see how the body absorbs and processes it, and to check for any side effects. It helps determine a safe dose for future studies.
Hear when a new Rheumatoid Arthritis (RA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.